Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Esschem is a U.S.-based manufacturer of specialty methacrylate polymers, monomers, and related acrylic chemistries used in dental, medical, cosmetic, audiology, and orthopedic applications. The company supplies bulk raw materials and components rather than finished medical devices, with core offerings spanning denture-base materials, impression materials, bone-cement polymer substrates, and custom acrylic systems. Esschem emphasizes domestic manufacturing, process scale-up from lab to commercial production, and quality systems aligned with regulated end markets, including ISO 13485-certified medical-device support. The business appears to operate as part of the Justi Group and works alongside affiliates such as Esstech, Esschem Europe, and EssPac to provide research, customization, manufacturing, and packaging resources. For a healthcare analyst, Esschem is best viewed as a commercial-stage specialty materials and manufacturing company serving medtech, dental, and adjacent healthcare product manufacturers rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Esschem.